Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 11,717 | $121.74 | $1,426,482.65 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 11 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.97 to $121.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherCommon Stock | 2,460 | $61.76 | $151,929.60 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 10 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,417 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherCommon Stock | 11,957 | $58.79 | $702,952.03 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 9 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,957 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 1,500 | $122.06 | $183,096.00 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 8 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.04 to $122.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 11,333 | $121.76 | $1,379,866.41 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 7 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.04 to $122.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherCommon Stock | 12,833 | $58.79 | $754,452.07 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 6 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,833 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 3,384 | $122.06 | $413,049.69 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 5 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.00 to $122.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 10,250 | $121.76 | $1,248,074.85 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 4 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherCommon Stock | 13,634 | $58.79 | $801,542.86 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 3 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,634 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 675 | $121.35 | $81,908.01 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 2 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · security: These securities are Restricted Stock Units. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.14 to $121.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 703 | $121.32 | $85,285.43 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 1 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F2 · shares: Shares purchased through Employee Stock Purchase Plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.14 to $121.31, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 20:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 1,903 | $121.29 | $230,824.19 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: These securities are Restricted Stock Units. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $121.11 to $121.31, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 14,676 | $43.62 Strike: $43.62 | $640,167.12 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · derivative · entry 8 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324 Underlying: Common Stock · 14,676 shares Expires 2021-07-20 F7 · price: Transaction is the exercise of a derivative security; see Column 2. F6 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 13,850 | $43.12 Strike: $43.12 | $597,212.00 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · derivative · entry 7 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Underlying: Common Stock · 13,850 shares Expires 2021-02-02 F7 · price: Transaction is the exercise of a derivative security; see Column 2. F6 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 2,700 | $122.08 | $329,602.50 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $122.01 to $122.18, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 11,150 | $121.69 | $1,356,861.34 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 13,850 | $43.12 | $597,212.00 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,231 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 2,186 | $122.08 | $266,875.19 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $122.04 to $122.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 12,490 | $121.75 | $1,520,632.52 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,567 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $121.04 to $122.02, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 14,676 | $43.62 | $640,167.12 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,057 Read SEC document |
| August 24, 2016 Filed Sep 13, 2016 20:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock · Derivative | 3,049 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · derivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,098 Underlying: Common Stock · 3,049 shares Expires 2018-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| August 24, 2016 Filed Sep 13, 2016 20:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Tax withholdingCommon Stock | 1,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,903 Read SEC document |
| August 24, 2016 Filed Sep 13, 2016 20:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock | 3,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-16-000003 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.